Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial
- 23 June 2001
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 357 (9273) , 2007-2011
- https://doi.org/10.1016/s0140-6736(00)05113-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstructionJournal of Allergy and Clinical Immunology, 1998
- Difficult asthmaEuropean Respiratory Journal, 1998
- A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonistJournal of Allergy and Clinical Immunology, 1998
- Montelukast, a Leukotriene-Receptor Antagonist, for the Treatment of Mild Asthma and Exercise-Induced BronchoconstrictionNew England Journal of Medicine, 1998
- Difficult-to-control asthma: Clinical characteristics of steroid-insensitive asthmaJournal of Allergy and Clinical Immunology, 1998
- Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroidsThorax, 1997
- Effect of oral prednisone on airway inflammatory mediators in atopic asthma.American Journal of Respiratory and Critical Care Medicine, 1994
- The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to AspirinAmerican Review of Respiratory Disease, 1993
- Differential Effects of Fluticasone Propionate on Allergen-evoked Bronchoconstriction and Increased Urinary Leukotriene E4ExcretionAmerican Review of Respiratory Disease, 1993
- Standardization of SpirometryAmerican Review of Respiratory Disease, 1988